Russell Frank Company’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2.53M Buy
94,198
+27,692
+42% +$678K ﹤0.01% 1729
2015
Q4
$1.93M Buy
66,506
+7,498
+13% +$216K ﹤0.01% 1854
2015
Q3
$1.64M Sell
59,008
-31,225
-35% -$1.13M ﹤0.01% 1967
2015
Q2
$3.72M Sell
90,233
-134,837
-60% -$4.94M 0.01% 1614
2015
Q1
$6.83M Sell
225,070
-60,918
-21% -$1.58M 0.01% 1067
2014
Q4
$5.66M Sell
285,988
-35,537
-11% -$795K 0.01% 1217
2014
Q3
$6.4M Sell
321,525
-10,329
-3% -$217K 0.01% 1134
2014
Q2
$7.22M Buy
331,854
+149
+0% +$2.65K 0.01% 1111
2014
Q1
$5.22M Sell
331,705
-86,329
-21% -$1.24M 0.01% 1276
2013
Q4
$5.35M Sell
418,034
-26,787
-6% -$320K 0.01% 1196
2013
Q3
$4.93M Buy
444,821
+162,505
+58% +$1.62M 0.01% 1340
2013
Q2
$2.33M Buy
+282,316
New +$2.37M ﹤0.01% 1683

Other funds holding RGEN

Russell Frank Company's RGEN Position: Q1 2016 in Review

Russell Frank Company increased its Repligen (RGEN) stake by 42% in Q1 2016, buying an estimated $678K and bringing the position to 94,198 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

Russell Frank Company first reported a position in RGEN in Q2 2013 and has held it in 12 quarters since. The position peaked at $7.22M in Q2 2014. 183 funds tracked by Wall St. Rank hold RGEN as of Q1 2016.

  • Russell Frank Company held 94,198 shares of Repligen worth $2.53M as of Q1 2016.
  • Russell Frank Company bought 27,692 Repligen shares in Q1 2016, an estimated $678K.
  • Repligen made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1729 holding.
  • Russell Frank Company first reported a position in Repligen in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's Repligen position peaked at $7.22M in Q2 2014.
  • 183 funds tracked by Wall St. Rank held Repligen as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.